Isofol Medical AB (publ) (ISOFOL.ST) - Stock Prices, Stock Peers & Analysis

Home
ISOFOL.ST

Company Name	Isofol Medical AB (publ)
Symbol	ISOFOL.ST
Currency	SEK
Price	0.616
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	99,493,240
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.45 - 1.24
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Roger Tell M.D., Ph.D.
Website	https://isofolmedical.com

An error occurred while fetching data.

About Isofol Medical AB (publ)

Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital.